bendroflumethiazide has been researched along with Bone Loss, Osteoclastic in 2 studies
Bendroflumethiazide: A thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE. It has been used in the treatment of familial hyperkalemia, hypertension, edema, and urinary tract disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p810)
bendroflumethiazide : A sulfonamide consisting of 7-sulfamoyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide in which the hydrogen at position 6 is substituted by a trifluoromethyl group and that at position 3 is substituted by a benzyl group.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Christoffersen, J | 1 |
Christoffersen, MR | 1 |
Jorgensen, FS | 1 |
Nielsen, SP | 1 |
2 other studies available for bendroflumethiazide and Bone Loss, Osteoclastic
Article | Year |
---|---|
The effect of bendroflumethiazide and hydrochlorothiazide on the rate of dissolution of calcium hydroxyapatite.
Topics: Bendroflumethiazide; Bone Resorption; Durapatite; Humans; Hydrochlorothiazide; Hydrolysis; Hydroxyap | 1984 |
Effects of long-term administration of bendroflumethiazide on bone metabolism in the rat.
Topics: Animals; Bendroflumethiazide; Bone and Bones; Bone Matrix; Bone Resorption; Calcium; Calcium Isotope | 1972 |